Autolus Therapeutics (AUTL) Cash from Investing Activities Growth (1y) (2018 - 2025)
Powered by 
Analysis
Autolus Therapeutics (AUTL) Cash from Investing Activities Growth (1y) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 90.55% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 91.53% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -41.67% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -157.08% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 26.37% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -89.24% |
| 10 | Autolus Therapeutics | 594.86 Mn | 393.23 Mn | 25.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 122.56% |
| Sep 30, 2025 | 470.71% |
| Jun 30, 2025 | 11,504.88% |
| Mar 31, 2025 | -11,072.05% |
| Dec 31, 2024 | -25,870.82% |
| Sep 30, 2024 | -540.12% |
| Jun 30, 2024 | 80.84% |
| Mar 31, 2024 | 85.28% |
| Dec 31, 2023 | -133.33% |
| Sep 30, 2023 | 77.96% |
| Jun 30, 2023 | -66.25% |
| Mar 31, 2023 | -369.78% |
| Dec 31, 2022 | 60.06% |
| Sep 30, 2022 | -76.04% |
| Jun 30, 2022 | -74.72% |
| Mar 31, 2022 | 59.42% |
| Dec 31, 2021 | 71.03% |
| Sep 30, 2021 | 4.64% |
| Jun 30, 2021 | 40.11% |
| Mar 31, 2021 | 27.95% |